Final Guidance For Reporting Adverse Events Gets Serious On Definitions
This article was originally published in The Tan Sheet
Executive Summary
A report of emergency room treatment connected to use of a dietary supplement may not connote a serious adverse event, FDA says in the final guidance on the reporting and recordkeeping of AE information for supplements
You may also be interested in...
FDA Says Supplement Adverse Event Under-Reporting Should Feed Growth
FDA published a how-to guide to push dietary supplement firms toward tighter compliance with the requirement to submit serious adverse event reports to the agency.
Trade Groups Back Matrixx On AER Disclosure In Supreme Court Case
Blanket disclosure of all adverse event reports would be "detrimental to investors and consumers," trade groups say in a brief supporting Matrixx Initiatives in its dispute with shareholders
FDA's Readiness Questioned In Electronic AER Comments
FDA's planned move to mandatory electronic filing of adverse event reports is raising concerns about costs for small businesses and the agency's ability to fully integrate its growing number of electronic filing requirements